PL1744760T3 - Kompozycja farmaceutyczna do ostrego leczenia glikokortykosteroidami - Google Patents
Kompozycja farmaceutyczna do ostrego leczenia glikokortykosteroidamiInfo
- Publication number
- PL1744760T3 PL1744760T3 PL05735475T PL05735475T PL1744760T3 PL 1744760 T3 PL1744760 T3 PL 1744760T3 PL 05735475 T PL05735475 T PL 05735475T PL 05735475 T PL05735475 T PL 05735475T PL 1744760 T3 PL1744760 T3 PL 1744760T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical compositions
- glucocorticoid therapy
- acute glucocorticoid
- acute
- therapy
- Prior art date
Links
- 230000001154 acute effect Effects 0.000 title 1
- 239000003862 glucocorticoid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56420604P | 2004-04-22 | 2004-04-22 | |
| SE0401032A SE0401032D0 (sv) | 2004-04-22 | 2004-04-22 | A new acute glucocorticoid therapy |
| PCT/EP2005/004399 WO2005102287A2 (en) | 2004-04-22 | 2005-04-21 | Pharmaceutical compositions for acute glucocorticoid therapy |
| EP05735475.5A EP1744760B1 (en) | 2004-04-22 | 2005-04-21 | Pharmaceutical compositions for acute glucocorticoid therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1744760T3 true PL1744760T3 (pl) | 2015-04-30 |
Family
ID=34965499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05735475T PL1744760T3 (pl) | 2004-04-22 | 2005-04-21 | Kompozycja farmaceutyczna do ostrego leczenia glikokortykosteroidami |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9925139B2 (pl) |
| EP (2) | EP2468266A3 (pl) |
| JP (2) | JP2007533697A (pl) |
| AU (1) | AU2005235369B2 (pl) |
| CA (1) | CA2563609C (pl) |
| IL (1) | IL178775A (pl) |
| MX (1) | MXPA06012088A (pl) |
| NZ (1) | NZ551336A (pl) |
| PL (1) | PL1744760T3 (pl) |
| WO (1) | WO2005102287A2 (pl) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
| US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
| US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
| US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
| US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US8017150B2 (en) | 2002-04-11 | 2011-09-13 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US20050058673A1 (en) | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
| SE0401031D0 (sv) | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
| MXPA06012088A (es) * | 2004-04-22 | 2007-08-14 | Duocort Ab | Composiciones farmaceuticas para terapia aguda con glucocorticoides. |
| JP5642929B2 (ja) | 2005-03-10 | 2014-12-17 | スリーエム イノベイティブ プロパティズ カンパニー | 微小生体汚染の低減方法 |
| MX2007010908A (es) | 2005-03-10 | 2007-12-05 | 3M Innovative Properties Co | Composiciones antimicrobianas que comprenden esteres de acidos hidroxicarboxilicos. |
| US20060229364A1 (en) * | 2005-03-10 | 2006-10-12 | 3M Innovative Properties Company | Antiviral compositions and methods of use |
| US7799331B2 (en) * | 2005-08-04 | 2010-09-21 | Taro Pharmaceutical North America, Inc. | Oral suspension of prednisolone acetate |
| FR2897267A1 (fr) * | 2006-02-16 | 2007-08-17 | Flamel Technologies Sa | Formes pharmaceutiques multimicroparticulaires pour administration per os |
| EP1867321A3 (en) * | 2006-06-07 | 2008-11-19 | Familplan Consulting Ltd. | A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent |
| US10092715B2 (en) * | 2006-09-27 | 2018-10-09 | Niconovum Usa, Inc. | Directional use |
| CA2704949A1 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| FR2926722B1 (fr) * | 2008-01-25 | 2010-09-03 | Substipharm Dev | Formulation pharmaceutique appropriee pour la preparation de comprimes orodispersibles de prednisolone |
| US20120183610A1 (en) * | 2009-04-07 | 2012-07-19 | Lennernaes Hans | glucocorticoid therapy |
| GR20090100230A (el) | 2009-04-14 | 2010-11-18 | Casso Pharmaceuticals Ε.Π.Ε, | Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης |
| EP2473161B1 (en) * | 2009-08-31 | 2017-05-17 | Dr. Reddy's Laboratories Ltd. | Topical formulations comprising a steroid |
| US10987361B2 (en) | 2010-02-08 | 2021-04-27 | Shenzhen Evergreen Therapeutics Co., Ltd. | Treating auto-immune and auto-inflammatory diseases |
| RU2016101363A (ru) * | 2010-02-08 | 2018-11-21 | Прэари Фармасьютикалз, Ллк | Способ лечения заболеваний, связанных с глюкокортикоидной нечувствительностью |
| US10993879B2 (en) | 2010-02-08 | 2021-05-04 | Shenzhen Evergreen Therapeutics Co., Ltd. | Pulmonary delivery of progestogen |
| US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
| GB201119985D0 (en) * | 2011-11-19 | 2012-01-04 | Diurnal Ltd | Treatment of adrenal insufficiency |
| ITMI20122002A1 (it) * | 2012-11-26 | 2014-05-27 | Farmacologico Milanese Srl Lab | Preparazioni farmaceutiche liquide stabilizzate |
| GB201308933D0 (en) | 2013-05-17 | 2013-07-03 | Diurnal Ltd | Paediatric composition |
| JP2016520656A (ja) * | 2013-06-03 | 2016-07-14 | トルマー，インコーポレイティド | コルチコステロイド組成物 |
| US10111956B2 (en) | 2013-06-03 | 2018-10-30 | Tolmar, Inc. | Corticosteroid compositions |
| US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
| BR112017008670B1 (pt) * | 2014-11-04 | 2023-05-16 | Acucort Ab | Película oral de dexametasona |
| US11291672B2 (en) | 2016-01-12 | 2022-04-05 | Grace Therapeutics Inc. | Betamethasone oral spray formulation and method of use to treat ataxia |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| CA3022840A1 (en) | 2016-05-05 | 2017-11-09 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
| WO2019132787A1 (en) * | 2017-12-29 | 2019-07-04 | World Medicine İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Improved metered-dose nasal spray formulation of beclomethasone dipropionate |
| GR1009641B (el) * | 2018-06-18 | 2019-11-12 | Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. | Ποσιμες συνθεσεις που περιλαμβανουν νατριοηλεκτρικη μεθυλοπρεδνιζολονη |
| US11160814B1 (en) | 2020-05-07 | 2021-11-02 | Ensemlble Group Holdings | Methods of treatment for disease from coronavirus exposure |
| EP4422607A4 (en) | 2021-10-25 | 2025-09-03 | Aquestive Therapeutics Inc | ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT |
| WO2025049713A1 (en) * | 2023-08-31 | 2025-03-06 | Fluidx Medical Technology, Inc. | Polyelectrolyte hydrogel formulations and methods for making and using the same |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2260384C3 (de) | 1972-12-09 | 1979-11-29 | Hoechst Ag, 6000 Frankfurt | Oral zu applizierendes Corticosteroid-Präparat |
| US4448774A (en) * | 1982-12-22 | 1984-05-15 | Fisons Corporation | Steroid formulation |
| US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
| JPS61280423A (ja) * | 1985-06-05 | 1986-12-11 | Kiyuukiyuu Yakuhin Kogyo Kk | 口腔内粘膜貼付剤 |
| EP0301006B1 (en) * | 1986-04-01 | 1992-05-06 | The Upjohn Company | Methylprednisolone/sodium carboxymethyl starch tablet composition |
| US4713243A (en) * | 1986-06-16 | 1987-12-15 | Johnson & Johnson Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
| US4855326A (en) * | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
| FR2621483B1 (fr) * | 1987-10-08 | 1991-09-20 | Medibrevex | Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation |
| US5004601A (en) * | 1988-10-14 | 1991-04-02 | Zetachron, Inc. | Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
| US5073374A (en) | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
| US5059426A (en) * | 1989-03-22 | 1991-10-22 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
| US5316772A (en) | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
| US5658956A (en) * | 1991-03-01 | 1997-08-19 | Warner-Lambert Company | Bioadhesive-wound healing compositions and methods for preparing and using same |
| US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5298256A (en) * | 1992-04-28 | 1994-03-29 | Corint, Ltd. | Desmopressin buccal patch composition |
| NZ278678A (en) | 1994-01-31 | 1998-03-25 | Yamanouchi Pharma Co Ltd | Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers |
| DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
| SI0869772T1 (en) * | 1995-12-27 | 2002-04-30 | Janssen Pharmaceutica N.V. | Bioadhesive solid dosage form |
| ES2234010T3 (es) | 1996-04-12 | 2005-06-16 | Novadel Pharma Inc. | Aerosol bucal polar. |
| AU3153797A (en) * | 1996-06-04 | 1998-01-05 | Procter & Gamble Company, The | A nasal spray containing an intranasal steroid and an antihistamine |
| US20010006677A1 (en) * | 1996-10-29 | 2001-07-05 | Mcginity James W. | Effervescence polymeric film drug delivery system |
| DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| DE19718012C1 (de) | 1997-04-29 | 1998-10-08 | Jenapharm Gmbh | Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe |
| AU2406299A (en) * | 1998-02-12 | 1999-08-30 | Centrapharm Inc. | Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect |
| ATE226429T1 (de) * | 1998-08-24 | 2002-11-15 | Procter & Gamble | Orale flüssige mucoadhäsive zusammensetzungen |
| US6428814B1 (en) * | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
| US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
| IT1318618B1 (it) * | 2000-07-10 | 2003-08-27 | A C R Applied Coating Res S A | Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi. |
| US6909120B2 (en) | 2000-11-10 | 2005-06-21 | Sharp Kabushiki Kaisha | Nitride semiconductor luminous element and optical device including it |
| GB0028575D0 (en) * | 2000-11-23 | 2001-01-10 | Elan Corp Plc | Oral pharmaceutical compositions containing cyclodextrins |
| US20030190360A1 (en) | 2001-03-13 | 2003-10-09 | Baichwal Anand R. | Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment |
| CN1531418A (zh) | 2001-03-22 | 2004-09-22 | ���ض������о�Ժ | 制造可溶性剂型 |
| MXPA03009772A (es) | 2001-04-24 | 2004-02-23 | Gen Hospital Corp | Metodos y composiciones para tratar lesiones orales y del esofago. |
| US6585997B2 (en) * | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| EP2279742A3 (en) * | 2001-10-05 | 2011-04-20 | Zalicus Inc. | Combinations for the treatment of immunoinflammatory disorders |
| US7846478B2 (en) * | 2002-01-31 | 2010-12-07 | Henkel Ag & Co. Kgaa | Bioadhesive composition |
| MXPA06012088A (es) * | 2004-04-22 | 2007-08-14 | Duocort Ab | Composiciones farmaceuticas para terapia aguda con glucocorticoides. |
| SE0401031D0 (sv) | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
-
2005
- 2005-04-21 MX MXPA06012088A patent/MXPA06012088A/es active IP Right Grant
- 2005-04-21 PL PL05735475T patent/PL1744760T3/pl unknown
- 2005-04-21 EP EP11191898A patent/EP2468266A3/en not_active Withdrawn
- 2005-04-21 JP JP2007508862A patent/JP2007533697A/ja active Pending
- 2005-04-21 AU AU2005235369A patent/AU2005235369B2/en not_active Expired
- 2005-04-21 WO PCT/EP2005/004399 patent/WO2005102287A2/en not_active Ceased
- 2005-04-21 CA CA2563609A patent/CA2563609C/en not_active Expired - Lifetime
- 2005-04-21 NZ NZ551336A patent/NZ551336A/en not_active IP Right Cessation
- 2005-04-21 US US11/587,512 patent/US9925139B2/en active Active
- 2005-04-21 EP EP05735475.5A patent/EP1744760B1/en not_active Expired - Lifetime
-
2006
- 2006-10-19 IL IL178775A patent/IL178775A/en active IP Right Grant
-
2012
- 2012-10-18 JP JP2012231012A patent/JP2013010804A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20090035375A1 (en) | 2009-02-05 |
| JP2013010804A (ja) | 2013-01-17 |
| EP1744760A2 (en) | 2007-01-24 |
| MXPA06012088A (es) | 2007-08-14 |
| JP2007533697A (ja) | 2007-11-22 |
| BRPI0510047A (pt) | 2007-10-16 |
| EP2468266A2 (en) | 2012-06-27 |
| EP1744760B1 (en) | 2015-01-07 |
| WO2005102287A2 (en) | 2005-11-03 |
| CA2563609A1 (en) | 2005-11-03 |
| WO2005102287A3 (en) | 2006-06-22 |
| US9925139B2 (en) | 2018-03-27 |
| AU2005235369A1 (en) | 2005-11-03 |
| EP2468266A3 (en) | 2012-10-24 |
| CA2563609C (en) | 2012-11-06 |
| NZ551336A (en) | 2010-04-30 |
| IL178775A0 (en) | 2007-02-11 |
| IL178775A (en) | 2015-10-29 |
| AU2005235369B2 (en) | 2010-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL178775A0 (en) | Pharmaceutical compositions for acute glucocorticoid therapy | |
| IL223545A0 (en) | Pharmaceutical compositions | |
| IL179809A0 (en) | Pharmaceutical compositions | |
| GB0408308D0 (en) | Pharmaceutical compositions | |
| IL177480A0 (en) | Pharmaceutical composition | |
| IL183986A0 (en) | Pharmaceutical compounds and compositions | |
| IL178776A0 (en) | Pharmaceutical compositions for glucocorticoid replacement therapy | |
| PL1837019T3 (pl) | Kompozycja farmaceutyczna rozpadająca się w ustach | |
| HU0401177D0 (en) | Pharmaceutical composition | |
| GB2411355B (en) | Pharmaceutical composition | |
| EP1805154A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0425255D0 (en) | Pharmaceutical composition | |
| ZA200701932B (en) | Pharmaceutical composition | |
| ZA200609685B (en) | Pharmaceutical compositions for acute glucocorticoid therapy | |
| ZA200700844B (en) | Quinolone-containing medicinal composition | |
| ZA200701931B (en) | Pharmaceutical composition | |
| GB0407351D0 (en) | Pharmaceutical compositions | |
| GB0400971D0 (en) | Pharmaceutical compositions | |
| GB0502792D0 (en) | Pharmaceutical compositions | |
| GB0411502D0 (en) | Pharmaceutical compositions | |
| GB0402799D0 (en) | Pharmaceutical composition | |
| GB0425256D0 (en) | Pharmaceutical composition | |
| GB0425259D0 (en) | Pharmaceutical composition | |
| GB0420173D0 (en) | Pharmaceutical compositions | |
| HU0400883D0 (en) | Pharmaceutical compositions |